Abstract
Recently, we demonstrated that the GM1 oligosaccharide, II3Neu5Ac-Gg4 (OligoGM1), administered to cultured murine Neuro2a neuroblastoma cells interacts with the NGF receptor TrkA, leading to the activation of the ERK1/2 downstream pathway and to cell differentiation. To understand how the activation of the TrkA pathway is able to trigger key biochemical signaling, we performed a proteomic analysis on Neuro2a cells treated with 50 μM OligoGM1 for 24 h. Over 3000 proteins were identified. Among these, 324 proteins were exclusively expressed in OligoGM1-treated cells. Interestingly, several proteins expressed only in OligoGM1-treated cells are involved in biochemical mechanisms with a neuroprotective potential, reflecting the GM1 neuroprotective effect. In addition, we found that the exogenous administration of OligoGM1 reduced the cellular oxidative stress in Neuro2a cells and conferred protection against MPTP neurotoxicity. These results confirm and reinforce the idea that the molecular mechanisms underlying the GM1 neurotrophic and neuroprotective effects depend on its oligosaccharide chain, suggesting the activation of a positive signaling starting at plasma membrane level.
Similar content being viewed by others
Abbreviations
- Ganglioside nomenclature:
-
is in accordance with IUPAC-IUBB recommendations [1]
- GM1:
-
II3Neu5Ac-Gg4Cer, β-Gal-(1-3)-β-GalNAc-(1-4)-[α-Neu5Ac-(2-3)]-β-Gal-(1-4)-β-Glc-Cer
- OligoGM1:
-
GM1 oligosaccharide, II3Neu5Ac-Gg4
- Ctrl:
-
Control
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- ERK1/2:
-
Extracellular signal-regulated protein kinases 1 and 2
- FBS:
-
Fetal bovine serum
- HPTLC:
-
High-performance silica gel thin-layer chromatography
- IPA:
-
Ingenuity Pathway Analysis
- MAPK:
-
Mitogen-activated protein kinase
- MPP+ :
-
1-Methyl-4-phenylpyridinium
- MPTP:
-
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride
- MS:
-
Mass spectrometry
- N2a:
-
Neuro2a cells
- NGF:
-
Nerve growth factor
- PBS:
-
Phosphate-buffered saline
- p-ERK1/2:
-
Phosphorylated ERK1/2
- p-TrkA:
-
Phosphorylated TrkA
- PM:
-
Plasma membrane
- PVDF:
-
Polyvinylidene difluoride
- RA:
-
Retinoic acid
- ROS:
-
Reactive oxygen species
- RRID:
-
Research resource identifiers
- Trk:
-
Neurotrophin tyrosine kinase receptor
- Tyr490:
-
Tyrosine 490
References
IUPAC-IUMB JCoBN (1998) Nomenclature of glycolipids. Carbohydr Res 312:167–175
Ledeen RW, Wu G (2015) The multi-tasked life of GM1 ganglioside, a true factotum of nature. Trends Biochem Sci 40:407–418
Ledeen RW, Wu G (2018a) Gangliosides of the nervous system. Methods Mol Biol 1804:19–55
Ledeen R, Wu G (2018b) Gangliosides, α-synuclein, and Parkinson’s disease. Prog Mol Biol Transl Sci 156:435–454
Schengrund CL (2015) Gangliosides: glycosphingolipids essential for normal neural development and function. Trends Biochem Sci 40:397–406
Schengrund CL, Prouty C (1988) Oligosaccharide portion of GM1 enhances process formation by S20Y neuroblastoma cells. J Neurochem 51:277–282
Aureli M, Mauri L, Ciampa MG, Prinetti A, Toffano G, Secchieri C, Sonnino S (2016) GM1 ganglioside: past studies and future potential. Mol Neurobiol 53:1824–1842
Schneider JS, Di Stefano L (1994) Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism. Neurology 44:748–750
Wu G, Lu ZH, Wang J, Wang Y, Xie X, Meyenhofer MF, Ledeen RW (2005) Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1. J Neurosci 25:11014–11022
Wu G, Lu ZH, Xie X, Ledeen RW (2014) Susceptibility of cerebellar granule neurons from GM2/GD2 synthase-null mice to apoptosis induced by glutamate excitotoxicity and elevated KCl: rescue by GM1 and LIGA20. Glycoconj J 21:3015–3313
Chiricozzi E, Pomè YD, Maggioni M, Di Biase E, Parravicini C, Palazzolo L, Loberto N, Eberini I et al (2017) Role of GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells. J Neurochem 143:645–659
Lipartiti M, Lazzaro A, Zanoni R, Mazzari S, Toffano G, Leon A (1991) Monosialoganglioside GM1 reduces NMDA neurotoxicity in neonatal rat brain. Exp Neurol 113:301–305
Nakamura K, Wu G, Ledeen RW (1992) Protection of neuro-2a cells against calcium ionophore cytotoxicity by gangliosides. J Neurosci Res 31:245–253
Bachis A, Rabin SJ, Del Fiacco M, Mocchetti I (2002) Ganglioside prevent excitotoxicity through activation of TrkB receptor. Neurotox Res 4:225–234
Zakharova IO, Sokolova TV, Vlasova YA, Furaev VV, Rychkova MP, Avrova NF (2014) GM1 ganglioside activates ERK1/2 and Akt downstream of Trk tyrosine kinase and protects PC12 cell against hydrogen peroxide toxicity. Neurochem Res 39:2262–2275
Schneider JS, Seyfried TN, Chiu HS, Kidd SK (2015) Intraventricular sialidase administration enhances GM1 ganglioside expression and is partially neuroprotective in a mouse model of Parkinson’s disease. PLoS One 10:12
Saulino MF, Schengrund CL (1993) Effects of specific gangliosides on the in vitro proliferation of MPTP-susceptible cells. J Neurochem 61:1277–1283
De Girolamo LA, Hargreaves AJ, Billett EE (2001) Protection from MPTP-induced neurotoxicity in differentiating mouse N2a neuroblastoma cells. J Neurochem 76:650–660
Nicotra A, Parvez SH (2002) Apoptotic molecules and MPTP-induced cell death. Neurotoxicol Teratol 24:599–605
Meredith GE, Rademacher DJ (2011) MPTP mouse models of Parkinson’s disease: an update. J Park Dis 1:19–33
Wiegandt H, Bücking HW (1970) Carbohydrate components of extraneuronal gangliosides from bovine and human spleen, and bovine kidney. Eur J Biochem 15:287–292
Tettamanti G, Bonali F, Marchesini S, Zambotti V (1973) A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim Biophys Acta 296:160–170
Acquotti D, Cantu L, Ragg E, Sonnino S (1994) Geometrical and conformational properties of ganglioside GalNAc-GD1a, IV4GalNAcIV3Neu5AcII3Neu5AcGgOse4Cer. Eur J Biochem 225:271–288
Chiricozzi E, Niemer N, Aureli M, Magini A, Loberto N, Prinetti A, Bassi R, Polchi A et al (2014) Chaperone therapy for GM2 gangliosidosis: effects of pyrimethamine on β-hexosaminidase activity in Sandhoff fibroblasts. Mol Neurobiol 50:159–167
Riboni L, Prinetti A, Bassi R, Caminiti A, Tettamanti G (1995) A mediator role of ceramide in the regulation of neuroblastoma Neuro2a cell differentiation. J Biol Chem 270:26868–26875
Wood ER, Kuyper L, Petrov KG, Hunter RN, Harris PA, Lackey K (2004) Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindoles. Bioorg Med Chem Lett 14:953–957
Ragg EM, Galbusera V, Scafaroni A, Negri A, Tedeschi G, Consonni A, Sessa F, Duranti M (2006) Inibitory properties and solution structure of a potent Bowman-Birk protease inhibitor from lentil (Lens culinaris L) seeds. FEBS J 273:4024–2039
Dell’Orco M, Milani P, Arrigoni L, Pansarasa O, Sardone V, Maffioli E, Polveraccio E, Bordoni M et al (2016) Hydrogen peroxide-mediated induction of SOD1 gene transcription is independent from Nrf2 in a cellular model of neurodegeneration. Biochim Biophys Acta 1859:315–323
Coccetti P, Tripodi F, Tedeschi G, Nonnis S, Marin O, Fantinato S, Cirulli C, Vanoni M et al (2008) The CK2 phosphorylation of catalytic domain of Cdc34 modulates its activity at the G1 to S transition in Saccharomyces cerevisiae. Cell Cycle 7:1–12
Maffioli E, Schulte C, Nonnis S, Scalvini FG, Piazzoni C, Lenardi C, Negri A, Milani P et al (2018) Proteomic dissection of nanotopography-sensitive mechanotransductive signalling hubs that foster neuronal differentiation in PC12 cells. Front Cell Neurosci 11:417
Chiricozzi E, Fernandez-Fernandez S, Nardicchi V, Almeida A, Bolaños JP, Goracci G (2010) Group IIA secretory phospholipase A2 (GIIA) mediates apoptotic death during NMDA receptor activation in rat primary cortical neurons. J Neurochem 112:1574–1583
Kim HY, Jeon H, Kim H, Koo S, Kim S (2018) Sophora flavescens Aiton decreases MPP+-induced mitochondrial dysfunction in SH-SY5Y cells. Front Aging Neurosci 10:119
Chiaretti S, Astro V, Chiricozzi E, de Curtis I (2016) Effects of the scaffold proteins liprin-α1, β1 and β2 on invasion by breast cancer cells. Biol Cell 108:65–75
Aureli M, Bassi R, Prinetti A, Chiricozzi E, Pappalardi B, Chigorno V, Di Muzio N, Loberto N et al (2012) Ionizing radiation increase the activity of cell surface glycohydrolases and plasma membrane ceramide content. Glycoconj J 29:585–597
Samarani M, Loberto N, Soldà G, Straniero L, Asselta R, Duga S, Lunghi G, Zucca FA et al (2018) A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest. FASEB J 32:5685–5702
Outeiro TF, Marques O, Kazantsev A (2008) Therapeutic role of sirtuins in neurodegenerative disease. Biochim Biophys Acta 1782:363–369
Yang W, Sheng H, Wang H (2016) Targeting the SUMO pathway for neuroprotection in brain ischaemia. Stroke Vasc Neurol 1:101–107
Bogorad AM, Lin KL, Marintchev A (2017) Novel mechanisms of eIF2B action and regulation by eIF2phosphorylation. Nucleic Acids Res 45:11962–11979
Grande V, Manassero G, Vercelli A (2014) Neuroprotective and anti-inflammatory roles of the phosphatase and tensin homolog deleted on chromosome ten (PTEN) inhibition in a mouse model of temporal lobe epilepsy. PLoS One 12:1–20
Vian J, Pereira C, Chavarria V, Köhler C, Stubbs B, Quevedo J, Kim SW, Carvalho AF et al (2017) The renin–angiotensin system: a possible new target for depression. BMC Med 15:144
Priesnitz C, Becker T (2018) Pathways to balance mitochondrial translation and protein import. Genes Dev 32:1285–1296
Bieri P, Greber BJ, Ban N (2018) High-resolution structures of mitochondrial ribosomes and their functional implications. Curr Opin Struct Biol 49:44–53
Chen K, Ho TS, Lin G, Tan KL, Rasband MN, Bellen HJ (2016) Loss of frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals. Elife 30:5
Almokhtar M, Wikvall K, Ubhayasekera SJKA, Bergquist J, Norlin M (2016) Motor neuron-like NSC-34 cells as a new model for the study of vitamin D metabolism in the brain. J Steroid Biochem Mol Biol 158:178–188
Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D, Harvey K, Deas E et al (2007) The mitochondrial protease HtrA2 is regulated by Parkinson’s disease-associated kinase PINK1. Nat Cell Biol 9:1243–1252
Sandhoff R, Schulze H, Sandhoff K (2018) Ganglioside metabolism in health and disease. Prog Mol Biol Transl Sci 156:1–62
Prinetti A, Chigorno V, Prioni S, Loberto N, Marano N, Tettamanti G, Sonnino S (2001) Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. J Biol Chem 276:21136–21145
Prinetti A, Prioni S, Chiricozzi E, Schuchman EH, Chigorno V, Sonnino S (2011) Secondary alterations of sphingolipid metabolism in lysosomal storage diseases. Neurochem Res 36:1654–1668
Chiricozzi E, Ciampa MG, Brasile G, Compostella F, Prinetti A, Nakayama H, Ekyalongo RC, Iwabuchi K et al (2015) Direct interaction, instrumental for signaling processes, between LacCer and Lyn in the lipid rafts of neutrophil-like cells. J Lipid Res 56:129–141
Grassi S, Chiricozzi E, Mauri L, Sonnino S, Prinetti A (2018) Sphingolipids and neuronal degeneration in lysosomal storage disorders. J Neurochem. https://doi.org/10.1007/s11064-018-2701-x
Mutoh T, Tokuda A, Miyadai T, Hamaguchi M, Fujiki N (1995) Ganglioside GM1 binds to the Trk proteins and regulates receptor function. Proc Natl Acad Sci 92:5087–5091
Rabin SJ, Mocchetti I (1995) GM1 ganglioside activates the high-affinity nerve growth factor receptor TrkA. J Neurochem 65:347–354
Rabin SJ, Bachis A, Mocchetti I (2002) Gangliosides activate Trk receptors by inducing the release of neurotrophin. J Biol Chem 51:49466–49472
Da Silva JS, Hasegawa T, Miyagi T, Dotti CG, Abab-Rodriguez J (2005) Asymmetric membrane ganglioside sialidase activity specifies axonal fate. Nat Neurosci 8:606–615
Facci L, Leon A, Tofffano G, Sonnino S, Ghidoni R, Tettamanti G (1984) Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1. J Neurochem 42:299–305
Valperta R, Valsecchi M, Rocchetta F, Aureli M, Prioni S, Prinetti A, Chigorno V, Sonnino S (2007) Induction of axonal differentiation by silencing plasma membrane-associated sialidase Neu3 in neuroblastoma cells. J Neurochem 100:708–719
Mutoh T, Hamano T, Yano S, Koga H, Yamamoto H, Furukawa K, Ledeen RW (2002) Stable transfection of GM1 synthase gene into GM1-deficient NG108-15 cells, CR-72 cells, rescues the responsiveness of Trk-neurotrophin receptor to its ligand, NGF. Neurochem Res 27:801–806
Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609–642
Brodeur GM, Minturn JE, Ho R, Simpson AM, Iyer R, Varela CR, Light JE, Kolla V et al (2009) Trk receptor expression and inhibition in neuroblastoma. Clin Cancer Res 15:3244–3250
Farooqui T, Franklin T, Pearl DK, Yates AJ (1997) Ganglioside GM1 enhances induction by nerve growth factor of a putative dimer of TrkA. J Neurochem 68:2348–2355
Singleton DW, Lu CL, Collela R, Roisen FJ (2000) Promotion of neurite outgrowth by protein kinase inhibitors and ganglioside GM1 in neuroblastoma cells involved MAP kinase ERK1/2. Int J Dev Neurosci 18:797–805
Duchemin AM, Ren Q, Mo L, Neff NH, Hadjiconstantinou M (2002) GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. J Neurochem 81:696–707
Ferrari G, Anderson BL, Stephens RM, Kaplan DR, Greene LA (1995) Prevention of apoptotic neuronal death by GM1 ganglioside. Involvement of Trk neurotrophin receptors. J Biol Chem 270:3074–3080
Rodriguez JA, Piddini E, Hasegawa T, Miyagi T, Dotti CG (2001) Plasma membrane ganglioside sialidase regulates axonal growth and regeneration in hippocampal neurons in culture. J Neurosci 21:8387–8395
Mutoh T, Tokuda A, Inokuchi J, Kuriyama M (1998) Glucosylceramide synthase inhibitor inhibits the action of nerve growth factor in PC12 cells. J Biol Chem 273:26001–26007
Svennerholm L, Bostrom K, Fredman P, Mansson JE, Rosengren B, Rynmark BM (1989) Human brain gangliosides: developmental changes from early fetal stage to advanced age. BBA 1005:109–117
Svennerholm L, Bostrom K, Junbjer B, Olsson L (1994) Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J Neurochem 63:1802–1811
Hadaczek P, Wu G, Sharma N, Ciesielska A, Bankiewicz K, Davidow AL, Lu ZH, Forsayeth J et al (2015) GDNF signaling implemented by GM1 ganglioside; failure in Parkinson’s disease and GM1-deficient murine model. Exp Neurol 263:177–189
Forsayeth J, Hadaczek P (2018) Ganglioside metabolism and Parkinson’s disease. Front Neurosci 12:45
Scheneider JS (2018) Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson’s disease. PLoS One 13:6
Schiumarini D, Loberto N, Mancini G, Bassi R, Giussani P, Chiricozzi E, Samarani M, Munari S et al (2017) Evidence for the involvement of lipid rafts and plasma membrane sphingolipid hydrolases in Pseudomonas aeruginosa infection of cystic fibrosis bronchial epithelial cells. Mediat Inflamm 103:445–456
Sonnino S, Chiricozzi E, Ciampa MG, Mauri L, Prinetti A, Toffano G, Aureli M (2017) Serum antibodies to glycans in peripheral neuropathies. Mol Neurobiol 54:1564–1567
Sonnino S, Chiricozzi E, Grassi S, Mauri L, Prioni S, Prinetti A (2018) Gangliosides in membrane organization. Prog Mol Biol Transl Sci 156:83–120
Aureli M, Samarani M, Loberto N, Chiricozzi E, Mauri L, Grassi S, Schiumarini D, Prinetti A et al (2018) Neuronal membrane dynamics as fine regulator of sphingolipid composition. Glycoconj J 35:397–402
Chiricozzi E, Loberto N, Schiumarini D, Samarani M, Mancini G, Tamanini A, Lippi G, Dechecchi MC et al (2018) Sphingolipids role in the regulation of inflammatory response: from leukocyte biology to bacterial infection. J Leukoc Biol 103:445–456
Varki A, Cummings RD, Aebi M, Packer NH, Seeberger PH, Esko JD, Stanley P, Hart G et al (2015) Symbol nomenclature for graphical representations of glycans. Glycobiology 25:1323–1324
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(DOCX 16006 kb)
Rights and permissions
About this article
Cite this article
Chiricozzi, E., Maggioni, M., di Biase, E. et al. The Neuroprotective Role of the GM1 Oligosaccharide, II3Neu5Ac-Gg4, in Neuroblastoma Cells. Mol Neurobiol 56, 6673–6702 (2019). https://doi.org/10.1007/s12035-019-1556-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-019-1556-8